CoreStock

Stock price

Track all markets on TradingView

Market cap

At each fiscal year end, then the latest quarter end: closing price × shares outstanding.

Show table
Intuitive Surgical market cap, annual
PeriodMarket cap
FY2016, ended Dec 31, 2016$24.6B
FY2017, ended Dec 31, 2017$41.0B
FY2018, ended Dec 31, 2018$54.8B
FY2019, ended Dec 31, 2019$68.6B
FY2020, ended Dec 31, 2020$96.3B
FY2021, ended Dec 31, 2021$129B
FY2022, ended Dec 31, 2022$93.0B
FY2023, ended Dec 31, 2023$119B
FY2024, ended Dec 31, 2024$186B
FY2025, ended Dec 31, 2025$201B
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)$141B

Revenue

By fiscal year, then the trailing 12 months

Show table
Intuitive Surgical revenue, annual
PeriodRevenue
FY2016, ended Dec 31, 2016$2.71B
FY2017, ended Dec 31, 2017$3.14B
FY2018, ended Dec 31, 2018$3.72B
FY2019, ended Dec 31, 2019$4.48B
FY2020, ended Dec 31, 2020$4.36B
FY2021, ended Dec 31, 2021$5.71B
FY2022, ended Dec 31, 2022$6.22B
FY2023, ended Dec 31, 2023$7.12B
FY2024, ended Dec 31, 2024$8.35B
FY2025, ended Dec 31, 2025$10.1B
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)$11.6B

Net income and free cash flow

By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.

Show table
Intuitive Surgical net income and free cash flow, annual
PeriodNet incomeFree cash flow
FY2016, ended Dec 31, 2016$738M$1.03B
FY2017, ended Dec 31, 2017$671M$953M
FY2018, ended Dec 31, 2018$1.13B$982M
FY2019, ended Dec 31, 2019$1.38B$1.17B
FY2020, ended Dec 31, 2020$1.06B$1.14B
FY2021, ended Dec 31, 2021$1.70B$1.75B
FY2022, ended Dec 31, 2022$1.32B$958M
FY2023, ended Dec 31, 2023$1.80B$750M
FY2024, ended Dec 31, 2024$2.32B$1.30B
FY2025, ended Dec 31, 2025$2.86B$2.49B
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)$2.96B$3.60B

Cash and cash equivalents

At each fiscal year end, then the latest quarter end.

Show table
Intuitive Surgical cash and cash equivalents, annual
PeriodCash and cash equivalents
FY2016, ended Dec 31, 2016$1.04B
FY2017, ended Dec 31, 2017$648M
FY2018, ended Dec 31, 2018$858M
FY2019, ended Dec 31, 2019$1.17B
FY2020, ended Dec 31, 2020$1.62B
FY2021, ended Dec 31, 2021$1.29B
FY2022, ended Dec 31, 2022$1.58B
FY2023, ended Dec 31, 2023$2.75B
FY2024, ended Dec 31, 2024$2.03B
FY2025, ended Dec 31, 2025$3.37B
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)$2.98B

Total debt

At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.

No figures for this period in the company’s filings.

Shares outstanding

At each fiscal year end, then the latest quarter end, adjusted for splits. Down 0.7% since FY16.

Show table
Intuitive Surgical shares outstanding, annual
PeriodShares outstanding
FY2016, ended Dec 31, 2016349M
FY2017, ended Dec 31, 2017337M
FY2018, ended Dec 31, 2018343M
FY2019, ended Dec 31, 2019348M
FY2020, ended Dec 31, 2020353M
FY2021, ended Dec 31, 2021358M
FY2022, ended Dec 31, 2022350M
FY2023, ended Dec 31, 2023352M
FY2024, ended Dec 31, 2024357M
FY2025, ended Dec 31, 2025355M
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)347M

Buybacks and new shares

By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.

Show table
Intuitive Surgical share buybacks and issuance, annual
PeriodBought backPaid to employees
FY2016, ended Dec 31, 2016$42.5M$178M
FY2017, ended Dec 31, 2017$2.27B$209M
FY2018, ended Dec 31, 2018$0$261M
FY2019, ended Dec 31, 2019$270M$336M
FY2020, ended Dec 31, 2020$134M$395M
FY2021, ended Dec 31, 2021$0$449M
FY2022, ended Dec 31, 2022$2.61B$513M
FY2023, ended Dec 31, 2023$416M$593M
FY2024, ended Dec 31, 2024$0$677M
FY2025, ended Dec 31, 2025$2.30B$788M
Trailing 12 months to Sep 30, 2026 (through Q3 FY2026)$4.62B$835M